This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

       

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Unit for Hours:H

Unit for Minutes: M

Loading text: $loading

Filter redirection page URL: /en-ie/events/

Login overlay needed?:

Filter Tags:All Medical indications|All Products|All Therapy Area

Filter Tags values when filtered by all Tags:All Medical indications|All Products|All Therapy Area

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successful

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successful

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:Not provided

Challenges of achieving good asthma control
Challenges of achieving good asthma control
Access free resources

Access free resources

Order resources to support your patients including, samples, demo devices, leaflets plus more.

See what's available

Educational webinars

Educational webinars

Join your peers and healthcare experts at live webinars run by GSK.

What's coming up?

Webinars on demand

Webinars on demand

Catch up on Asthma & COPD video webinars anytime from the comfort of your own office.

Explore more

Access free resources

Access free resources

Order resources to support your patients including, samples, demo devices, leaflets plus more.

See what's available

Educational webinars

Educational webinars

Join your peers and healthcare experts at live webinars run by GSK.

What's coming up?

Webinars on demand

Webinars on demand

Catch up on Asthma & COPD video webinars anytime from the comfort of your own office.

Explore more

Respiratory Products

Relvar Ellipta

Relvar Ellipta

25% more patients improve asthma control vs. other ICS/LABAs in everyday clinical practice. 1

Explore more

Trelegy Ellipta

Trelegy▼ Ellipta

Discover more about the only once daily COPD single inhaler triple therapy available in Ireland.

Explore more

Anoro Ellipta

Anoro▼ Ellipta

Discover more about the only once-daily LAMA/LABA to demonstrate superiority in lung function within the class.

Explore more

Respiratory Products

Relvar Ellipta

Relvar Ellipta

25% more patients improve asthma control vs. other ICS/LABAs in everyday clinical practice. 1

Explore more

Trelegy Ellipta

Trelegy▼ Ellipta

Discover more about the only once daily COPD single inhaler triple therapy available in Ireland.

Explore more

Anoro Ellipta

Anoro▼ Ellipta

Discover more about the only once-daily LAMA/LABA to demonstrate superiority in lung function within the class. 2

Explore more

More Information

Dovato tile

Dovato (dolutegravir and lamivudine)

An innovative treatment for your patients living with HIV-1. Dovato is a complete two-drug regimen, offering convenient dosing, available in a once daily pill.

Learn more

Prescribing information

Bexsero tile

Explore Bexsero - Meningococcal Group B Vaccine

Bexsero is indicated for the active immunisation of individuals from 2 months of age and older against invasive meningococcal disease(IMD) caused by Neisseria meningitidis group B.

Learn more

Prescribing information

Impact Trial

Using dual therapy or triple therapy for your patients?

The IMPACT trial was the first trial to assess the efficacy and safety of single inhaler Triple Therapy TRELEGY▼ Ellipta vs. an ICS/LABA (FF/VI 92/22 mcg) and a LAMA/LABA (UMEC/VI). 2

Explore the IMPACT data

Prescribing information

GSK Registration

Stay Informed

Sign up to receive email alerts from GSK including important supply updates, new product information and events we are running.

Register Now

Abbreviations

FEV1, forced expiratory volume in one second; FF, fluticasone furoate; ICS, inhaled corticosteroid; LABA, long-acting ß2-agonist; LAMA, long-acting muscarinic antagonist; OD, once-daily; UMEC, umeclidinium; VI, vilanterol

References:

  1. Woodcock A et al. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel-group, randomised controlled trial. Lancet 2017;290:22247-2255.
  2. Lipson DA et al. N Engl J Med 2018; 378:1671–1680.

Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971, medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

▼These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting side effects you may get.

Trade marks are owned by or licensed to the GSK group of companies.